Annual CAPEX
$2.75 B
+$514.00 M+22.96%
31 December 2023
Summary:
Novartis AG annual capital expenditures is currently $2.75 billion, with the most recent change of +$514.00 million (+22.96%) on 31 December 2023. During the last 3 years, it has risen by +$168.00 million (+6.50%). NVS annual CAPEX is now -21.46% below its all-time high of $3.50 billion, reached on 31 December 2015.NVS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$799.00 M
+$71.00 M+9.75%
30 September 2024
Summary:
Novartis AG quarterly capital expenditures is currently $799.00 million, with the most recent change of +$71.00 million (+9.75%) on 30 September 2024. Over the past year, it has increased by +$116.00 million (+16.98%). NVS quarterly CAPEX is now -40.28% below its all-time high of $1.34 billion, reached on 31 December 2007.NVS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$3.47 B
+$116.00 M+3.46%
30 September 2024
Summary:
Novartis AG TTM capital expenditures is currently $3.47 billion, with the most recent change of +$116.00 million (+3.46%) on 30 September 2024. Over the past year, it has increased by +$998.00 million (+40.44%). NVS TTM CAPEX is now -4.91% below its all-time high of $3.65 billion, reached on 30 September 2014.NVS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVS CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.0% | +17.0% | +40.4% |
| 3 y3 years | +6.5% | +48.2% | +14.9% |
| 5 y5 years | +4.0% | +42.2% | +52.6% |
NVS CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +23.0% | -30.9% | +167.2% | -1.5% | +95.9% |
| 5 y | 5 years | at high | +23.0% | -30.9% | +167.2% | -1.5% | +95.9% |
| alltime | all time | -21.5% | +228.5% | -40.3% | +264.8% | -4.9% | +1482.7% |
Novartis AG CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $799.00 M(+9.8%) | $3.47 B(+3.5%) |
| June 2024 | - | $728.00 M(-37.0%) | $3.35 B(-4.8%) |
| Mar 2024 | - | $1.16 B(+47.6%) | $3.52 B(+27.9%) |
| Dec 2023 | $2.75 B(+23.0%) | $783.00 M(+14.6%) | $2.75 B(+11.5%) |
| Sept 2023 | - | $683.00 M(-23.9%) | $2.47 B(+18.4%) |
| June 2023 | - | $898.00 M(+130.8%) | $2.08 B(+17.8%) |
| Mar 2023 | - | $389.00 M(-21.9%) | $1.77 B(-21.0%) |
| Dec 2022 | $2.24 B(-12.4%) | $498.00 M(+66.6%) | $2.24 B(-2.8%) |
| Sept 2022 | - | $299.00 M(-48.7%) | $2.30 B(-9.4%) |
| June 2022 | - | $583.00 M(-32.1%) | $2.54 B(-0.5%) |
| Mar 2022 | - | $859.00 M(+52.8%) | $2.56 B(+0.0%) |
| Dec 2021 | $2.56 B(-1.1%) | $562.00 M(+4.3%) | $2.56 B(-15.3%) |
| Sept 2021 | - | $539.00 M(-9.7%) | $3.02 B(-2.8%) |
| June 2021 | - | $597.00 M(-30.4%) | $3.10 B(+4.9%) |
| Mar 2021 | - | $858.00 M(-16.1%) | $2.96 B(+14.5%) |
| Dec 2020 | $2.58 B(+14.5%) | $1.02 B(+63.2%) | $2.58 B(+17.6%) |
| Sept 2020 | - | $627.00 M(+38.7%) | $2.20 B(+3.0%) |
| June 2020 | - | $452.00 M(-6.4%) | $2.13 B(-6.7%) |
| Mar 2020 | - | $483.00 M(-24.1%) | $2.29 B(+1.2%) |
| Dec 2019 | $2.26 B(-14.8%) | $636.00 M(+13.2%) | $2.26 B(-0.6%) |
| Sept 2019 | - | $562.00 M(-7.0%) | $2.27 B(-10.9%) |
| June 2019 | - | $604.00 M(+32.7%) | $2.55 B(+5.0%) |
| Mar 2019 | - | $455.00 M(-30.0%) | $2.43 B(-8.3%) |
| Dec 2018 | $2.65 B(+15.4%) | $650.00 M(-22.7%) | $2.65 B(+5.2%) |
| Sept 2018 | - | $841.00 M(+74.1%) | $2.52 B(+7.3%) |
| June 2018 | - | $483.00 M(-28.3%) | $2.34 B(-2.9%) |
| Mar 2018 | - | $674.00 M(+30.1%) | $2.41 B(+5.2%) |
| Dec 2017 | $2.29 B(-20.3%) | $518.00 M(-22.6%) | $2.29 B(-10.3%) |
| Sept 2017 | - | $669.00 M(+21.0%) | $2.56 B(-1.7%) |
| June 2017 | - | $553.00 M(-0.2%) | $2.60 B(-4.5%) |
| Mar 2017 | - | $554.00 M(-29.1%) | $2.72 B(-5.4%) |
| Dec 2016 | $2.88 B(-17.9%) | $781.00 M(+9.4%) | $2.88 B(-6.1%) |
| Sept 2016 | - | $714.00 M(+5.8%) | $3.07 B(-2.1%) |
| June 2016 | - | $675.00 M(-4.8%) | $3.13 B(-10.5%) |
| Mar 2016 | - | $709.00 M(-26.8%) | $3.50 B(-0.2%) |
| Dec 2015 | $3.50 B(+3.0%) | $968.00 M(+24.1%) | $3.50 B(+3.9%) |
| Sept 2015 | - | $780.00 M(-25.1%) | $3.37 B(-6.1%) |
| June 2015 | - | $1.04 B(+45.7%) | $3.59 B(+2.3%) |
| Mar 2015 | - | $715.00 M(-14.4%) | $3.51 B(+3.1%) |
| Dec 2014 | $3.40 B(+0.8%) | $835.00 M(-16.4%) | $3.40 B(-6.6%) |
| Sept 2014 | - | $999.00 M(+3.8%) | $3.65 B(+3.4%) |
| June 2014 | - | $962.00 M(+58.2%) | $3.52 B(+5.7%) |
| Mar 2014 | - | $608.00 M(-43.5%) | $3.34 B(-1.2%) |
| Dec 2013 | $3.38 B | $1.08 B(+22.4%) | $3.38 B(+13.3%) |
| Sept 2013 | - | $879.00 M(+13.7%) | $2.98 B(+4.3%) |
| June 2013 | - | $773.00 M(+18.9%) | $2.86 B(+2.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2013 | - | $650.00 M(-4.3%) | $2.80 B(+0.9%) |
| Dec 2012 | $2.77 B(+16.1%) | $679.00 M(-10.1%) | $2.77 B(+0.2%) |
| Sept 2012 | - | $755.00 M(+5.7%) | $2.77 B(+6.6%) |
| June 2012 | - | $714.00 M(+14.4%) | $2.60 B(+3.6%) |
| Mar 2012 | - | $624.00 M(-7.3%) | $2.50 B(+4.9%) |
| Dec 2011 | $2.39 B(+6.9%) | $673.00 M(+15.2%) | $2.39 B(-2.9%) |
| Sept 2011 | - | $584.00 M(-6.4%) | $2.46 B(+8.5%) |
| June 2011 | - | $624.00 M(+23.3%) | $2.27 B(-1.0%) |
| Mar 2011 | - | $506.00 M(-32.0%) | $2.29 B(+2.6%) |
| Dec 2010 | $2.23 B(-18.3%) | $744.00 M(+89.8%) | $2.23 B(-10.1%) |
| Sept 2010 | - | $392.00 M(-39.5%) | $2.48 B(-4.8%) |
| June 2010 | - | $648.00 M(+44.6%) | $2.61 B(-2.7%) |
| Mar 2010 | - | $448.00 M(-54.9%) | $2.68 B(-2.0%) |
| Dec 2009 | $2.73 B(+18.0%) | $994.00 M(+92.6%) | $2.73 B(+17.1%) |
| Sept 2009 | - | $516.00 M(-28.2%) | $2.33 B(-3.0%) |
| June 2009 | - | $719.00 M(+42.7%) | $2.41 B(-0.5%) |
| Mar 2009 | - | $504.00 M(-15.3%) | $2.42 B(+4.4%) |
| Dec 2008 | $2.32 B(-26.1%) | $595.00 M(+1.2%) | $2.32 B(-24.3%) |
| Sept 2008 | - | $588.00 M(-19.5%) | $3.06 B(-2.0%) |
| June 2008 | - | $730.00 M(+81.1%) | $3.12 B(+3.6%) |
| Mar 2008 | - | $403.00 M(-69.9%) | $3.01 B(-3.8%) |
| Dec 2007 | $3.13 B(+40.5%) | $1.34 B(+105.8%) | $3.13 B(+7.7%) |
| Sept 2007 | - | $650.00 M(+4.3%) | $2.91 B(+6.4%) |
| June 2007 | - | $623.00 M(+19.3%) | $2.73 B(+11.6%) |
| Mar 2007 | - | $522.00 M(-53.1%) | $2.45 B(+9.9%) |
| Dec 2006 | $2.23 B(+61.6%) | $1.11 B(+133.8%) | $2.23 B(+29.1%) |
| Sept 2006 | - | $476.00 M(+40.4%) | $1.73 B(+12.4%) |
| June 2006 | - | $339.00 M(+12.3%) | $1.54 B(+5.2%) |
| Mar 2006 | - | $302.00 M(-50.5%) | $1.46 B(+5.8%) |
| Dec 2005 | $1.38 B(-4.1%) | $610.00 M(+114.0%) | $1.38 B(+4.0%) |
| Sept 2005 | - | $285.00 M(+8.4%) | $1.33 B(-0.9%) |
| June 2005 | - | $263.00 M(+18.5%) | $1.34 B(-4.5%) |
| Mar 2005 | - | $222.00 M(-60.1%) | $1.40 B(-2.6%) |
| Dec 2004 | $1.44 B(-6.7%) | $557.00 M(+87.5%) | $1.44 B(-10.0%) |
| Sept 2004 | - | $297.00 M(-8.9%) | $1.60 B(-0.9%) |
| June 2004 | - | $326.00 M(+25.9%) | $1.61 B(+1.9%) |
| Mar 2004 | - | $259.00 M(-63.9%) | $1.58 B(+2.6%) |
| Dec 2003 | $1.54 B(+33.2%) | $717.00 M(+130.5%) | $1.54 B(+86.8%) |
| Sept 2003 | - | $311.00 M(+5.1%) | $826.00 M(+60.4%) |
| June 2003 | - | $296.00 M(+35.2%) | $515.00 M(+135.2%) |
| Mar 2003 | - | $219.00 M | $219.00 M |
| Dec 2002 | $1.16 B(-16.1%) | - | - |
| Dec 2001 | $1.38 B(+64.8%) | - | - |
| Dec 2000 | $838.00 M(-2.7%) | - | - |
| Dec 1999 | $861.00 M(-24.9%) | - | - |
| Dec 1998 | $1.15 B | - | - |
FAQ
- What is Novartis AG annual capital expenditures?
- What is the all time high annual CAPEX for Novartis AG?
- What is Novartis AG annual CAPEX year-on-year change?
- What is Novartis AG quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Novartis AG?
- What is Novartis AG quarterly CAPEX year-on-year change?
- What is Novartis AG TTM capital expenditures?
- What is the all time high TTM CAPEX for Novartis AG?
- What is Novartis AG TTM CAPEX year-on-year change?
What is Novartis AG annual capital expenditures?
The current annual CAPEX of NVS is $2.75 B
What is the all time high annual CAPEX for Novartis AG?
Novartis AG all-time high annual capital expenditures is $3.50 B
What is Novartis AG annual CAPEX year-on-year change?
Over the past year, NVS annual capital expenditures has changed by +$514.00 M (+22.96%)
What is Novartis AG quarterly capital expenditures?
The current quarterly CAPEX of NVS is $799.00 M
What is the all time high quarterly CAPEX for Novartis AG?
Novartis AG all-time high quarterly capital expenditures is $1.34 B
What is Novartis AG quarterly CAPEX year-on-year change?
Over the past year, NVS quarterly capital expenditures has changed by +$116.00 M (+16.98%)
What is Novartis AG TTM capital expenditures?
The current TTM CAPEX of NVS is $3.47 B
What is the all time high TTM CAPEX for Novartis AG?
Novartis AG all-time high TTM capital expenditures is $3.65 B
What is Novartis AG TTM CAPEX year-on-year change?
Over the past year, NVS TTM capital expenditures has changed by +$998.00 M (+40.44%)